Cargando…

Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression

While chemotherapy delivery by nanocarriers has modestly improved the survival prospects of pancreatic ductal adenocarcinoma (PDAC), additional engagement of the immune response could be game changing. We demonstrate a nano-enabled approach for accomplishing robust anti-PDAC immunity in syngeneic mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Jianqin, Liu, Xiangsheng, Liao, Yu-Pei, Salazar, Felix, Sun, Bingbing, Jiang, Wen, Chang, Chong Hyun, Jiang, Jinhong, Wang, Xiang, Wu, Anna M., Meng, Huan, Nel, Andre E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703845/ https://www.ncbi.nlm.nih.gov/pubmed/29180759 http://dx.doi.org/10.1038/s41467-017-01651-9

Ejemplares similares

Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
por: Lu, Jianqin, et al.
Publicado: (2018)

Retraction of “Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway”
por: Lu, Jianqin, et al.
Publicado: (2021)

Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1
por: Liu, Xiangsheng, et al.
Publicado: (2021)

Transcytosis - An effective targeting strategy that is complementary to “EPR effect” for pancreatic cancer nano drug delivery
por: Liu, Xiangsheng, et al.
Publicado: (2019)

Defeating Melanoma Through a Nano-Enabled Revision of Hypoxic and Immunosuppressive Tumor Microenvironment
por: Yang, Wenzhe, et al.
Publicado: (2023)

A novel immunochemotherapy based on immunogenicity-activated and immunosuppression-reversed biomimetic nanoparticles
por: Zuo, Huaqin, et al.
Publicado: (2022)

Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy
por: Chen, Hu, et al.
Publicado: (2022)

Immunogenic cell death in cancer immunotherapy
por: Choi, Minji, et al.
Publicado: (2023)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
por: Zhang, Xuehua, et al.
Publicado: (2022)

Immunogenic cell death-related classifications in breast cancer identify precise immunotherapy biomarkers and enable prognostic stratification
por: Wang, Xue, et al.
Publicado: (2022)

Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy
por: Zhang, Yalei, et al.
Publicado: (2021)

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano-del Valle, Alfonso, et al.
Publicado: (2019)

Cancer immunotherapy by immunosuppression
por: Prehn, Richmond T, et al.
Publicado: (2010)

Identification of Immunogenic Cell Death-Related Signature for Glioma to Predict Survival and Response to Immunotherapy
por: Sun, Zhiqiang, et al.
Publicado: (2022)

Immunogenic-cell-killing and immunosuppression-inhibiting nanomedicine
por: Wang, Ying, et al.
Publicado: (2020)

Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Maes, Ken, et al.
Publicado: (2019)

Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
por: Palanivelu, Lalitha, et al.
Publicado: (2023)

Modulation of immunosuppressive cells and noncoding RNAs as immunotherapy in osteosarcoma
por: Xia, Yidan, et al.
Publicado: (2022)

MnO(2) Nanoflowers Induce Immunogenic Cell Death under Nutrient Deprivation: Enabling an Orchestrated Cancer Starvation‐Immunotherapy
por: Yang, Yannan, et al.
Publicado: (2020)

Stimuli-responsive nano vehicle enhances cancer immunotherapy by coordinating mitochondria-targeted immunogenic cell death and PD-L1 blockade
por: Li, Qiuyi, et al.
Publicado: (2022)

Nanocatalytic bacteria disintegration reverses immunosuppression of colorectal cancer
por: Jiang, Han, et al.
Publicado: (2022)

Role of the immunosuppressive microenvironment in immunotherapy
por: Tormoen, Garth W., et al.
Publicado: (2018)

Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy
por: Chen, Yu-Jia, et al.
Publicado: (2023)

Immunogenic Cell Death and Elimination of Immunosuppressive Cells: A Double-Edged Sword of Chemotherapy
por: Fumet, Jean-David, et al.
Publicado: (2020)

Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment
por: Chen, Wuzhen, et al.
Publicado: (2021)

Immunosuppressive IBD drugs and COVID-19 vaccine immunogenicity
por: Hindson, Jordan
Publicado: (2022)

Programmable Unlocking Nano‐Matryoshka‐CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response
por: Yang, Jin, et al.
Publicado: (2021)

Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano Del Valle, Alfonso, et al.
Publicado: (2019)

The role of immunogenic cell death in gastrointestinal cancer immunotherapy (Review)
por: Songjang, Worawat, et al.
Publicado: (2021)

Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy
por: Sun, Yajie, et al.
Publicado: (2021)

Nanotechnology-Assisted Immunogenic Cell Death for Effective Cancer Immunotherapy
por: Guo, Yichen, et al.
Publicado: (2023)

Triple‐Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo‐Immunotherapy in Preclinical Cancer Models
por: Shi, Xiaowei, et al.
Publicado: (2023)

Cancer-induced immunosuppression can enable effectiveness of immunotherapy through bistability generation: A mathematical and computational examination
por: Garcia, Victor, et al.
Publicado: (2020)

Nano‐optogenetic immunotherapy
por: Huang, Kai, et al.
Publicado: (2022)

Tumor-Derived Exosomes in Immunosuppression and Immunotherapy
por: Olejarz, Wioletta, et al.
Publicado: (2020)

Bioengineering of nano metal-organic frameworks for cancer immunotherapy
por: Chong, Gaowei, et al.
Publicado: (2020)

Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
por: Adkins, Irena, et al.
Publicado: (2015)

Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy
por: Cruickshank, Brianne, et al.
Publicado: (2018)

Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma
por: Zong, Yuan, et al.
Publicado: (2023)

Immunosuppressive plasma cells impede T cell-dependent immunogenic chemotherapy
por: Shalapour, Shabnam, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jucdip4u1mc2nfccg145fr8u5a